Abbott
As on 02 Oct, 2025 | 01:29 IST
| Open | 134.78 |
| Previous Close | 133.94 |
| Beta | 0.07 |
| High | 135.44 |
| Low | 129.10 |
| TTM EPS See historical trend | 4.90(+10.11% YoY) |
| 52 Week High | 141.07 |
| 52 Week Low | 110.89 |
| TTM PE See historical trend | 27.24(High PE) |
| Mkt. Cap ($ Billion) | 231.48 |
| Dividend Yield | 1.71 |
Advanced Chart
*Delayed by 20 seconds.
MC Technicals
| Days | |
|---|---|
| 5 | 133.48 |
| 10 | 134.44 |
| 20 | 133.42 |
| 50 | 131.5 |
| 100 | 132.11 |
| 200 | 129.21 |
Returns
| 1 Week | -1.79% | |
| 1 Month | 0.60% | |
| 3 Months | -1.93% | |
| YTD | 18.04% | |
| 1 Year | 17.10% | |
| 3 Years | 37.93% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 186.03 | 0.33 | 448.29 | 18.60 | 10.00 | 3.29 | 186.56/141.30 | 5.02 | Very Bullish |
| Abbott | 133.46 | -0.36 | 231.48 | 27.24 | 4.90 | 1.71 | 141.07/110.89 | 0.60 | Very Bullish |
| Thermo Fisher Scientific | 530.66 | 9.41 | 202.35 | 24.24 | 21.89 | 0.41 | 616.30/385.72 | 7.63 | Bullish |
| Intuitive Surgical | 438.02 | -2.06 | 155.26 | 54.41 | 8.05 | -- | 614.58/429.72 | -7.48 | Very Bearish |
| Pfizer | 27.23 | 6.87 | 154.19 | 8.03 | 3.39 | 7.07 | 30.41/21.05 | 9.98 | Bullish |
Market news
- Stocks finish week higher; Wall Street at record highsSeptember 20, 2025 7:43 AM
- Nasdaq notches record high close, traders look to Fed meetingSeptember 13, 2025 9:16 AM
- Wall Street indexes end lower as jobs data fuels economic worriesSeptember 6, 2025 10:13 AM
- S&P 500 ends lower as Dell and Nvidia dropAugust 30, 2025 10:46 AM
About the company
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.